4//SEC Filing
POWERS BRADLEY J 4
Accession 0001126234-24-000012
CIK 0001126234other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 5:51 PM ET
Size
7.5 KB
Accession
0001126234-24-000012
Insider Transaction Report
Form 4
LUMOS PHARMA, INC.(LUMO)
POWERS BRADLEY J
Principal Executive Officer
Transactions
- Tax Payment
Common Stock
2024-02-01$3.01/sh−240$722→ 5,749 total
Holdings
- 27(indirect: By Spouse)
Common Stock
Footnotes (5)
- [F1]Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 667 previously reported restricted stock units ("RSUs") granted to the Reporting Person.
- [F2]Includes 1,125 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person on April 1, 2024, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
- [F3]Includes 218 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person on February 1, 2025, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
- [F4]Includes 450 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on February 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
- [F5]Includes 675 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on February 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
Documents
Issuer
LUMOS PHARMA, INC.
CIK 0001126234
Entity typeother
Related Parties
1- filerCIK 0001784080
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 5:51 PM ET
- Size
- 7.5 KB